Weve entered a new divide in human existence: B.G
Since then, a number of preclinical studies have examined its possible impacts on inflammation, gastrointestinal health, and tissue repair
Go easy on very sugary drinks, and ask your doctor or pharmacist what fits your other medications, especially if you take a blood pressure or water pill
J Endocr Soc (2019) 3:154573
Michael Palladinetti, global head of business development and licensing at Sanofi, told delegates attending Bio Europe Spring in Barcelona, Spain last week that history has shown us time and time again that no one has the monopoly on the next wave of innovation. Citing the recent GLP-1 wave, Palladinetti said the industry has a bit of fear of missing out (FOMO) and paid kudos to Lily and Novo for staying in the space. He added how innovation is also very difficult and that industry players need to have a broad view. Both firms are pioneers in the diabetes space, having launched their own versions of insulin over 100 years ago
Comparative efficacy and safety of GLP-1 receptor agonists for weight reduction: A model-based meta-analysis of placebo-controlled trials
